Tissue Regenix Group plc (AIM:TRX)
London · Delayed Price · Currency is GBP · Price in GBX 32.00
-1.50 (-4.48%)
Aug 5, 2025, 4:32 PM GMT+1
CALT Market Cap
Tissue Regenix Group has a market cap or net worth of 23.86 million as of August 5, 2025. Its market cap has decreased by -51.45% in one year.
Market Cap
23.86M
Enterprise Value
30.12M
Revenue
22.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
$32.00
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 23.86M, a decrease of -41.80%. That is a compound annual growth rate of -3.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 23.51M | -45.00% |
| Dec 31, 2024 | 42.74M | 16.73% |
| Dec 29, 2023 | 36.61M | -7.68% |
| Dec 30, 2022 | 39.66M | 5.65% |
| Dec 31, 2021 | 37.54M | -0.93% |
| Dec 31, 2020 | 37.89M | 227.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 172.19B |
| GSK plc | 56.39B |
| Haleon | 32.84B |
| Smith & Nephew | 10.12B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.27B |
| HUTCHMED (China) | 2.26B |
| Oxford Nanopore Technologies | 1.92B |